Nova Cosmetic Center & Orlando Medical Spa - It's You Only Better! - Cosmetically, It's Allergan's Botox By A Long Shot

Contact Us

For More Information Or To Schedule Your Consultation Click Here

Monthly Specials

See Your Procedure

Click here to see your
cosmetic surgery procedure
in 3 dimensional imaging!
Click here to see your cosmetic surgery procedure in 3 dimensional imaging!

What our Clients Say

Lux V Acne Treatment Better Than Pro-Active!

Dear Nova Cosmetic Center

Thank you so much for taking the time and patience to make me look better. I have loved my Lux V treatments. Been to the Dermatologist for years, tried pro-active, accutane and I cant believe the results I received at Nova. I sincerely appreciate you all. You are very special. Your special kindness is so appreciated!

Again, my thanks,
Ellen.

Click Here To Schedule A FREE Consultation

or Give Us A Call At 407-965-3986

Cosmetically, It's Allergan's Botox By A Long Shot

By Christine Bittar

Media Post Publications

March 19, 2007

DERMATOLOGISTS HAVE BEEN JUMPING ON the bandwagon to accommodate aging Baby Boomers, so it shouldn't come as a surprise that Botox injections were the single most popular non-invasive cosmetic procedure last year.

That information comes from recent data released by the American Society of Aesthetic Plastic Surgery (ASAPS).

In addition, Allergan's Botox and hyaluronic acid dermal fillers (namely Juvederm, also from Allergan), were the fastest-growing noninvasive cosmetic procedures in 2006, up 33% versus 2005, and, for the first time, those injectable procedures are the top two most popular non-invasive treatments (as opposed to complementary and/or competitive treatments like microdermabrasion and chemical peels).

This comes as Allergan, via agency Grey Healthcare, broke its first ad campaign for Juvederm Ultra and Juvederm Ultra Plus. Print ads, which broke in March monthlies, have Allergan's newer and lesser-known product tagged "new from the creators of Botox Cosmetic." A TV campaign for Juvederm hasn't been finalized; however, it's likely that one will hit the airwaves by this fall.